Literature DB >> 16162436

Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports.

Matthew Walker1, Helen Cross, Shelagh Smith, Camilla Young, Jean Aicardi, Richard Appleton, Sarah Aylett, Frank Besag, Hannah Cock, Robert DeLorenzo, Franck Drislane, John Duncan, Colin Ferrie, Denson Fujikawa, William Gray, Peter Kaplan, Micheal Koutroumanidis, Mary O'Regan, Perrine Plouin, Josemir Sander, Rod Scott, Simon Shorvon, David Treiman, Claude Wasterlain, Udo Wieshmann.   

Abstract

In April 2004, a group of physicians with an interest in nonconvulsive status epilepticus representing a spectrum of opinion met in Oxford, sponsored by the Epilepsy Research Foundation (a charitable organization), to discuss and debate the definition, diagnosis and treatment of nonconvulsive status epilepticus. We felt that such a meeting would be useful, as nonconvulsive status epilepticus is a subject that provokes strong reactions, perhaps largely due to the relative lack of evidence and the surfeit of opinion. The meeting was arranged such that there were formal talks followed by a discussion led by one of the attendees. We present here the extended abstracts of the main talks with the points raised by the discussants. Despite disagreements on certain issues there was much in the way of consensus. First, it was agreed that nonconvulsive status epilepticus is a term that covers a range of disparate conditions with varying prognoses and treatments. The agreed definition was thus suitably vague, A<<Nonconvulsive status epilepticus is a term used to denote a range of conditions in which electrographic seizure activity is prolonged and results in nonconvulsive clinical symptomsA>>. Secondly, it was agreed that even within a specific condition (e.g. complex partial status epilepticus), the prognosis and treatment depends upon the context in which the condition occurs (e.g. in the critically ill, in coma, in the A<<walking woundedA>> and in people with prior epilepsy). Perhaps, most importantly it was agreed that we lacked good clinical data, and the challenge was to design good studies for a condition that is underrecognised and often difficult to diagnose.

Entities:  

Mesh:

Year:  2005        PMID: 16162436

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  24 in total

1.  Cyclic hyperammoniemic encephalopathy and epileptiform triphasic waves: problems in differential diagnosis with nonconvulsive status epilepticus.

Authors:  Alberto Primavera; Daniela Audenino
Journal:  Neurol Sci       Date:  2009-02-24       Impact factor: 3.307

2.  Cefixime-induced nonconvulsive status epilepticus.

Authors:  F Anzellotti; L Ricciardi; D Monaco; F Ciccocioppo; I Borrelli; H Zhuzhuni; M Onofrj
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

Review 3.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

Review 4.  Seizures and epilepsy in cancer patients.

Authors:  Edward K Avila; Jerome Graber
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

5.  Guiding Antiepileptic Therapy in a Pediatric Patient with Severe Meningoencephalitis and Decompressive Craniectomy with the Use of Amplitude-Integrated Electroencephalography.

Authors:  Karl F Schettler; Beatrice Heineking; Silvia Fernandez-Rodriguez; Angelika Pilger; Nikolaus Alexander Haas
Journal:  J Pediatr Intensive Care       Date:  2016-08-08

6.  Central neurological complications in critically ill patients with malignancies.

Authors:  Stéphane Legriel; Hélène Marijon; Michael Darmon; Virginie Lemiale; Jean-Pierre Bedos; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

7.  Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes.

Authors:  Utku Uysal; Mark Quigg; Brennen Bittel; Nancy Hammond; Theresa I Shireman
Journal:  Epilepsy Res       Date:  2015-07-26       Impact factor: 3.045

8.  Cortical regional hyperperfusion in nonconvulsive status epilepticus measured by dynamic brain perfusion CT.

Authors:  M Hauf; J Slotboom; A Nirkko; F von Bredow; C Ozdoba; R Wiest
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

Review 9.  Nonconvulsive status epilepticus in adults - insights into the invisible.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

10.  Outcomes in 140 critically ill patients with status epilepticus.

Authors:  Stéphane Legriel; Bruno Mourvillier; Nicolas Bele; Jose Amaro; Pierre Fouet; Philippe Manet; François Hilpert
Journal:  Intensive Care Med       Date:  2007-10-27       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.